Thomasm · Newsroom
Creative Diagnostics Launches Advanced Mammalian DNA Residue Assay Kits (qPCR) for Enhanced Biopharmaceutical Research
Creative Diagnostics Launches Advanced Mammalian DNA Residue Assay Kits (qPCR) for Enhanced Biopharmaceutical ResearchSeptember 27, 2024
Creative Diagnostics Introduces T-2/HT-2 Toxin Test Reagents to Ensure Food Safety
Creative Diagnostics Introduces T-2/HT-2 Toxin Test Reagents to Ensure Food SafetySeptember 27, 2024
Creative Diagnostics Announces Respiratory Syncytial Virus Animal Models to Advance RSV Research
Creative Diagnostics Announces Respiratory Syncytial Virus Animal Models to Advance RSV Research
September 27, 2024
Creative Diagnostics Announces Cutting-Edge DNA/RNA Methylation Antibodies for Cancer Research
Creative Diagnostics Announces Cutting-Edge DNA/RNA Methylation Antibodies for Cancer ResearchSeptember 27, 2024
Patulin Test Reagents for Food Safety Applications
Patulin Test Reagents for Food Safety ApplicationsJuly 29, 2024
Reliable Hemagglutination Assay for Virus and Antibody Detection
Reliable Hemagglutination Assay for Virus and Antibody DetectionJuly 29, 2024
High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development
High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay DevelopmentJuly 29, 2024
Creative Diagnostics Introduces Comprehensive Range of Ochratoxin Test Reagents for Enhanced Food Safety Analysis
Creative Diagnostics Introduces Comprehensive Range of Ochratoxin Test Reagents for Enhanced Food Safety AnalysisJune 29, 2024
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral ResearchJune 29, 2024
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine ResearchJune 29, 2024
Creative Diagnostics Announces Availability of High-Affinity Anti Venom Antibodies for Research Applications
Creative Diagnostics Announces Availability of High-Affinity Anti Venom Antibodies for Research ApplicationsMay 29, 2024
Creative Diagnostics Introduces Immunofluorescence Assay Testing Services for Virology Research
Creative Diagnostics Introduces Immunofluorescence Assay Testing Services for Virology ResearchMay 29, 2024
Creative Diagnostics Launches Comprehensive Fumonisin Test Reagents for Precise Food Safety Analysis
Creative Diagnostics Launches Comprehensive Fumonisin Test Reagents for Precise Food Safety AnalysisMay 29, 2024
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food SafetyFebruary 27, 2024
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple PathogensFebruary 27, 2024
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Creative Diagnostics Announces New AAV Reagent Solutions for Gene TherapyFebruary 27, 2024
Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research
Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer ResearchJanuary 26, 2024
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Announces MDT Services for Measuring Antibacterial EffectivenessJanuary 26, 2024
Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Rapid Robenidine Test Reagents for the Analysis of Anticoccidial ResiduesJanuary 23, 2024
Macrophage Migration Inhibitory Factor Reagents for Research Applications
Macrophage Migration Inhibitory Factor Reagents for Research ApplicationsDecember 27, 2023
New MBC Assay for Antibacterial Testing
Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing.December 27, 2023
Test Reagents for Dapsone
Creative Diagnostics announced the launch of a range of new reagents for the analysis of Dapsone in food, including Dapsone Antibodies & Antigens, Dapsone ELISA Kits, and Dapsone Screen Tests.December 27, 2023
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Announces New CLDN6 Solutions for Cancer ResearchNovember 28, 2023
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing ServicesNovember 28, 2023
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Carbamazepine Test ReagentsNovember 28, 2023
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches New Azaperone Test Reagents for Research ApplicationsOctober 29, 2023
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches Checkerboard Assay ServicesOctober 29, 2023
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA DevelopmentOctober 29, 2023
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics has recently launched a series of Antimicrobial Synergy Testing Services to the reserch community.September 21, 2023
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics has announced a series of new ELISA Kits to assist researchers in studing the mechanisms of autoimmunity.September 21, 2023
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics announced the launch of its new Antimicrobial Susceptibility Testing (AST) services.August 18, 2023
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics has announced a series of new reagent solutions to assist researchers in the bioanalysis of ADCs.August 18, 2023
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics has announced the launch of new reagent solutions for herpesvirus research.July 7, 2023
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics has introduced its new qPCR Assay to the research community.July 7, 2023
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry.June 19, 2023
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases.
June 19, 2023
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses.May 19, 2023
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics announces the launch of its new line of Calprotectin Reagents to accelerate research in inflammatory diseases.May 19, 2023
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics recently introduced a new line of low endotoxin antibodies to biopharmaceutical research laboratories.April 26, 2023
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds.April 26, 2023
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.March 29, 2023
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.
March 29, 2023
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics recently introduced the TCID50 Assay Service suitable for drug sensitivity tests, infectious units quantification, the determination of virus doses, as well as virus release studies.February 16, 2023
Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics recently introduced a series of HPV vaccine development products.February 16, 2023